CS Paper Radar

Benchmarking graph-based models for in-silico toxicity prediction in drug discovery

Noel Suarez-Barro, Manuel Lama, Juan C. Vidal

cs.LG q-bio.BMq-bio.QM ·submitted 2026-09-29 13:31 UTC · v1
code/data

Abstract

Drug discovery is a costly and high-risk process, where toxicity-related failures remain a major cause of attrition in both preclinical and clinical stages. As a result, accurate early prediction of chemical toxicity is essential to reduce downstream costs and improve compound prioritization. In this context, graph deep learning (GDL) has emerged as a powerful paradigm for toxicity prediction, leveraging molecular graph representations to learn directly from chemical structure with improved expressivity over traditional approaches. Despite the growing number of proposed models, current literature-based comparisons are often difficult to interpret due to inconsistencies in datasets, preprocessing pipelines, and evaluation protocols. To address this limitation, we introduce a unified and standardized benchmarking framework for GDL-based toxicity prediction. We systematically evaluate more than 20 representative approaches under consistent experimental conditions and across multiple datasets and partitioning strategies, enabling a fair and reproducible comparison of model performance. In addition, we complement this empirical study with a structured literature analysis to contextualize existing methodological trends and performance claims. Our results provide a clearer and more reliable assessment of the current state of the field, highlighting both the strengths and limitations of existing graph-based approaches. To support transparency and reproducibility, we release our benchmarking framework as open-source software https://gitlab.citius.gal/noel.suarez/benchtox, allowing the community to evaluate and compare models under consistent conditions.

Closest papers

Nearest neighbours by meaning across the whole index.

BiGSyn: A Bi-Level Heterogeneous Graph Contrastive Learning Framework for Interpretable Drug Synergy Prediction

cs.AI ·2026-11-16 ·Senquan Wang, Hui Fang, Haoran Nan, Xingwei Wang, Qiang He
publishedbenchmark similarity 0.72
Abstract · 2026 IEEE International Conference on Data Mining (ICDM 2026)

Drug combination therapy has become a mainstream of modern medicine, with the potential to enhance efficacy, reduce toxicity, and overcome drug resistance. However, identifying synergistic drug combinations remains challenging, as it requires modeling complex interactions across multiple biological scales---from atom-level molecular structures to entity-level relations in biological networks. Existing approaches typically model these levels in isolation, overlooking complementary signals and long-range dependencies. To address these limitations, we propose BiGSyn, a Bi-level heterogeneous Graph contrastive learning framework for drug Synergy prediction. Specifically, BiGSyn leverages heterogeneous graph transformers to extract high-order dependencies from molecular graphs and biological networks, and introduces a bi-level contrastive learning objective to bridge the cross-level semantic gap. Extensive experiments on two benchmark datasets show that BiGSyn consistently outperforms state-of-the-art baselines. Moreover, its attention mechanism highlights key molecular substructures and biological interactions driving synergy, providing interpretable insights.

0.18

ToxLens: A Reproducible Graph-Learning Framework for Leakage-Aware, Uncertainty-Calibrated Molecular Toxicity Prediction

cs.LG ·2026-08-31 ·Magnus H. Strømme, Alex G. C. de Sá, David B. Ascher
benchmark similarity 0.72
Abstract · 39 pages, 5 figures

Molecular toxicity prediction is increasingly used to prioritise compounds before experimental testing, but conventional benchmark performance can overstate practical utility when structurally related molecules occur across training and test folds. We introduce ToxLens, a reproducible multi-task graph-learning framework for 11 toxicity endpoints spanning Ames mutagenicity, acute oral toxicity, hERG inhibition, and Tox21 nuclear-receptor and stress-response assays. The workflow combines conservative chemical curation, sphere-exclusion filtering, a leakage-aware UMAP-HDBSCAN split, parallel graph and global-feature encoders joined by late concatenation, temperature-scaled Monte Carlo dropout with conformal-style prediction sets, applicability-domain analysis, and SHAP-guided toxicophore discovery with occlusion controls. On the leakage-controlled test fold, a five-seed soft-voting ensemble achieved a Matthews correlation coefficient score of 0.44, an area under the receiver operating characteristic curve score of 0.83, and an area under the precision-recall curve score of 0.58. It exceeded four ECFP4-based shallow baselines on all 11 endpoints under the same split and validation-based threshold-selection protocol. Controlled ablations showed that the global pathway was important, whereas late concatenation outperformed the tested gated and feature-wise linear modulation fusion variants. Conformal-style prediction sets revealed substantial endpoint-specific variation in set efficiency, and discrimination and calibration improved with similarity to the training domain. Retraining on fixed published Tox21 Challenge and TDA folds produced competitive, but not uniformly state-of-the-art, performance. SHAP-guided occlusion and consensus subgraph mining yielded model-derived structural hypotheses, 44 of which contained at least one occurrence that passed the predefined counterfactual criteria.

0.30

HierDTA: Hierarchical Structure-Aware Representation Learning for Drug--Target Affinity Prediction

cs.LG cs.AI ·2026-10-19 ·Huangchao Xu, Baohua Zhang, Qian Liu, Zhong Jin, Yi Du
published similarity 0.72
Abstract · 20 pages, 7 figures

Drug--target affinity (DTA) prediction plays an important role in computer-aided drug discovery, where reliable computational models can help prioritize compound--protein pairs before experimental validation. A key challenge in DTA prediction is to effectively mine multi-level molecular information from drug structures while accurately modeling the binding-site environment of target proteins. To address these issues, we introduce HierDTA, a hierarchical structure-aware framework for DTA prediction. \textcolor{black}{HierDTA represents each drug as an atom--motif heterogeneous graph and introduces an augmentation module that propagates functional-motif semantics to the corresponding atoms. For proteins, kinase-domain structures are converted into residue interaction graphs. The resulting atom and residue representations are integrated using cross-attention to capture pair-specific relationships, while molecule fingerprints and pretrained ESM-2 embeddings provide complementary global information. Compared with state-of-the-art methods, HierDTA achieves superior performance on the Davis dataset across all metrics and attains the highest \(r_m^2\) of 0.791 on KIBA. It also exhibits strong generalization under cold-start settings, particularly on KIBA, where MSE is reduced by 21.7\% in the unseen-protein scenario. Ablation study and interpretability analysis supported the contributions of the hierarchical augmentation and interaction components.} Case studies further showed that HierDTA provided early enrichment of candidate bioactive compounds. These results indicate that HierDTA is an effective framework for affinity prediction and target-specific virtual screening.

0.31

SMILESGNN: Interpretable Clinical Toxicity Prediction via SMILES-Graph Cross-Attention Fusion

cs.LG cs.AI ·2026-09-23 ·Quang Minh Nguyen, Thuy Quynh Nguyen, Duc Minh Le, Ho Nhat Minh Nguyen, Thanh Long Dai Doan +1 more
published similarity 0.72
Abstract

Drug toxicity prediction is critical for reducing late-stage attrition in drug discovery, yet remains challenging due to severe class imbalance, scaffold-based generalization, and the clinical need for interpretable predictions. Single-modality approaches-SMILES Transformers or graph neural networks capture complementary aspects of molecular structure, while sequence-only models cannot directly provide graph-attributed explanations. We present SMILESGNN, a multimodal architecture that fuses a SMILES Transformer encoder and a GATv2 graph encoder via cross-attention, and SMILESGNN-PT, a variant using a ChemBERTa-2 pretrained backbone. The design retains an explicit graph branch within the predictive pipeline, supporting GNNExplainer-based analysis of substructures associated with toxic predictions. On ClinTox, SMILESGNN achieves AUC-ROC 0.987 and F1 0.906 with only 0.4M parameters, performing competitively with a strong SMILESTransformer and a larger ChemBERTa-2/GATv2 concat-fusion baseline. On Tox21 (12 tasks), SMILESGNN-PT obtains mean AUC-ROC 0.750, comparable to ChemBERTa-2 alone and the same-backbone concat-fusion baseline. Overall, the results suggest that cross-attention is a practical fusion alternative that preserves competitive predictive performance while enabling graph-based interpretability support.

0.25

MolLedger: An Additive Graph Neural Network with Chemically Grounded ADME Attributions

cs.LG ·2026-08-31 ·Christina X. Ji
theory similarity 0.72
Abstract

Optimizing absorption, distribution, metabolism, and excretion (ADME) is an important part of small molecule drug discovery. Many machine learning models have been built to predict ADME properties to facilitate this optimization process, but explaining model predictions is challenging. We propose a new graph neural network architecture with built-in atom attributions. Our model MolLedger learns a global context vector for each molecule and a per-atom head to output atom scores that sum to the predicted property. The atom scores are regularized to align with relevant chemical properties. We prove that MolLedger is a universal approximator and demonstrate empirically that the new architecture obtains explainability with little effect on performance. We show that the interpretations from MolLedger are faithful, concordant with held-out physical properties, and align with the changes between matched molecular pairs. Our case studies comparing interpretations from multiple methods on molecular pairs reveal that MolLedger is much better at producing sensible explanations for predicted property changes.

0.25

Fragment-Level Graph Encoding for Interpretable Molecular Property Prediction

cs.LG stat.ML ·2026-10-21 ·Rafael Lopes Almeida, Ina Pöhner
publishedcode/data similarity 0.71
Abstract · 12 pages, 3 figures, 6-page appendices, to be published in Proceedings of the 8th Northern Lights Deep Learning Conference (NLDL), 2027. For…

Graph neural networks (GNNs) are among the standard tools for molecular property prediction, but the atom-level explanations of their predictions are hard for medicinal chemists to act on. We propose a change of input representation rather than a new model: molecules are encoded as fragment-level graphs from BRICS decomposition, where each node is a synthetically meaningful fragment whose features are the element-wise sum of its atoms' features. Because only the representation changes, any message-passing GNN and any post-hoc attribution method produces explanations at the resolution of functional groups instead of single atoms. Across four architectures, four prediction tasks, and two explainers under scaffold splits, fragment-level encoding matches atom-level test accuracy on roughly five-fold smaller graphs. Integrated-Gradients attributions recover known pharmacophores above chance on two enzyme targets, namely BACE at 1.5 times the chance rate, and PTR1 at 3.2 times. A like-for-like comparison against an aggregated atom-level baseline shows that post-hoc aggregation is not a stable substitute: its BACE hit rate range both exceeds and falls below the fragment model's hit rate depending on two arbitrary aggregation choices, whereas fragment-level training yields a single convention-free attribution at no predictive cost. The code is available at: https://github.com/4D-Lab/frame

0.36

MT-RGCN-DTI: A Multi-Task Relational Graph Convolutional Network for Drug-Target Interaction Prediction

cs.LG cs.AI ·2026-11-15 ·Dheeran Sankaran, R Yadunandan, Daniele Santoni, Nimisha Ghosh
benchmarkcode/data similarity 0.70
Abstract

Prediction of drug-target interaction (DTI) has become a very crucial part of drug discovery. With the increase in the data volume, it has become very important to improve prediction accuracy by integrating multiple data sources. In this regard, utilising multiple resources in the form of heterogeneous information network to address DTI prediction can be rewarding. In this work, we propose a heterogeneous information network based multi-task DTI prediction model which leverages the advantages of relation graph convolutional network (RGCN). To achieve this, the model employs drug-target interaction network, drug-drug similarity network and protein-protein similarity network to construct a heterogeneous information network. Moreover, we use a knowledge graph embedding scoring functions to model interactions between drug and targets, specifically DistMult and ComplEx as decoders over the learned node representations. We performed extensive experiments on multiple benchmark datasets and compared with state-of-the-art methods. We observed that the proposed model shows competitive performance, thereby confirming the effectiveness of our approach. The codes and datasets are available at https://github.com/Dheeran-S/MT-RGCN-DTI/.

0.19

Molecular Prior Networks

cs.LG cs.AIcs.CE ·2026-11-03 ·Pawel Gomoluch, Anthony Bradley
publishedbenchmark similarity 0.69
Abstract · Accepted to the NeurIPS 2026 Workshop on AI for Drug Discovery: Bridging the Translation Gap

Predicting affinity between small molecules and their protein targets remains one of the central problems in drug discovery. Due to the substantial cost of wet-lab experiments, machine learning models of drug-target affinity are usually trained on relatively small datasets, ranging from tens to hundreds of molecules. Given the inherent difficulty of generalization between different targets and chemical series, existing datasets of protein-ligand affinities are typically not used for new projects. At the same time, tabular foundation models, including Prior-data Fitted Networks, have recently shown how transformers can be used to solve machine learning problems in a single forward pass of the network, after being trained over a large corpus of, typically, synthetic datasets. Inspired by that line of work, we propose a novel affinity modelling approach, in which the labels of the query molecules are predicted from the labelled support molecules in a single forward pass of a transformer model. The model is trained on thousands of existing affinity datasets, enabling it to capture the general patterns of molecular activity across different targets, chemical series and dataset sizes. For the smallest support sets, our model matches the state of the art on the regression variant of the FS-Mol benchmark, while being faster than existing methods, thanks to the lack of task-specific training. A comparison against a reduced variant of our architecture, which amounts to kernel regression in a meta-learned feature space, shows that the predictive performance of the transformer model is only partially explained by simple molecular similarity.

0.25